Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Acelyrin Inc.

Clinical trials sponsored by Acelyrin Inc., explained in plain language.

Now part of Alumis Inc. ALMS NASDAQ

A biopharmaceutical company developing therapies for immunology and inflammation.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

New drug trial for painful skin condition halted early

Disease control Terminated

This study tested a drug called izokibep for people with moderate to severe hidradenitis suppurativa, a chronic skin condition causing painful lumps. The trial aimed to see if izokibep could reduce skin abscesses and inflammation. It included 258 adults who had not responded to o…

Phase: PHASE3 • Sponsor: ACELYRIN Inc. • Aim: Disease control

Last updated Jun 27, 2026 07:54 UTC